Insights into Company Bills & Payments

Ashok Leyland ↗

1948 📍 Chennai, Tamil Nadu, India Active NSE ASHOKLEY CIN L34101TN1948PLC000105 Automobile Manufacturers
Search companies

Key Metrics of Ashok Leyland

Revenue₹44,007 Cr▲ 13.6% YoYFY 2025-26
EBITDA₹5,699 Cr▲ 7.8% YoY
Net profit₹3,566 Cr▲ 7.9% YoY
Net worth₹13,113 Cr▲ 13.8% YoY
Employees11,908
Competitors10identified

About Ashok Leyland

Sectors

Automobile ManufacturersPassenger CarsCommercial Vehicles & BusesAuto Components, Forging & CastingGears, Steering, Brakes & Systems

Company details

Website
ashokleyland.com
Founded
1948
Registered office
No.1, Sardar Patel Road Guindy, Chennai, In-tn, 600032
Listed
NSE: ASHOKLEY · ₹145.00

Operational Areas of Ashok Leyland

Automobile Manufacturers›Passenger Cars
Automobile Manufacturers›Commercial Vehicles & Buses
Auto Components, Forging & Casting›Gears, Steering, Brakes & Systems

Company summary

Entity details

CINL34101TN1948PLC000105
LEI code3358001BZKWERVWYCK35
State codeTN
PIN code600032
Current legal nameASHOK LEYLAND
Classification—
Listing statusListed (NSE: ASHOKLEY)
Registration no.000105
Company age78 years, 1 months
PAN—
CountryIndia
CityChennai
StateTamil Nadu
Current statusActive
Date of incorporation07 Sep 1948
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count11,908

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code34101
Description of main activityManufacture of motor vehicles, trailers and auto components
Description of business activityManufacture of motor vehicles, trailers and auto components
SectorAutomobile Manufacturers · Commercial Vehicles & Buses

Share price · NSE: ASHOKLEY

ASHOKLEY on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 1 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 31 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

ICRA · 09 Oct 2026 ICRA AA+ Stable outlook · Short term A1+ · Reaffirmed
CARE · 21 Sep 2026 CARE AA+ Stable outlook · Short term A1+ · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on recordNo changesince Apr 2019
Rating actions151 up · 0 down
Liquidity (ICRA)Strong

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
09 Oct 2026ICRAReaffirmed AA+A1+Stable₹7,379 Cr View
21 Sep 2026CAREReaffirmed AA+A1+Stable₹6,000 Cr View
02 Jun 2026ICRAReaffirmed AA+A1+Stable₹7,479 Cr View
22 Sep 2025CAREReaffirmed AA+A1+Stable₹6,400 Cr View
26 Sep 2024CAREUpgraded (from AA) AA+A1+Stable₹6,500 Cr View
04 Oct 2023CAREReaffirmed AAA1+Stable₹6,700 Cr View
07 Nov 2022CAREReaffirmed AAA1+Stable₹4,100 Cr View
07 Jan 2022CAREReaffirmed AAA1+Negative₹4,200 Cr View
08 Apr 2021CAREReaffirmed AAA1+Negative₹4,200 Cr View
26 Mar 2021CAREReaffirmed —A1+—₹2,000 Cr View
06 May 2020CARERevised AA—Negative₹4,200 Cr View
01 Apr 2020CAREOther ———— View
24 Mar 2020CAREReaffirmed AA+A1+Negative₹9,900 Cr View
28 Jun 2019CAREReaffirmed —A1+—₹2,000 Cr View
05 Apr 2019CAREReaffirmed AA+A1+Stable₹2,600 Cr View

Credit strengths (ICRA, Oct 2026)

+ Established market presence in the domestic CV industry

ALL is the second-largest player in the domestic M&HCV industry with a healthy market share over the past several years (M&HCV trucks market share stood at around 30% (excluding defence) in FY2026), aided by its long operational track record, strong brand and well-diversified distribution and service network.

+ Diversification across CV and non-CV business provides stability to revenues

The company has diversified its presence beyond the domestic M&HCV trucks segment, with an increasing proportion of sales from other segments, including LCV trucks, buses, defence, international operations, etc., which imparts stability to revenues and earnings, especially during segmental downcycles.

+ Comfortable capitalisation metrics and strong liquidity

ALL’s robust market share, along with sustained growth in the CV industry over last few years, has supported revenue growth momentum.

Credit challenges

− Moderate capex expected for EV segment over the medium term

The company is manufacturing e -buses and e-LCVs under Switch Mobility Automotive Limited (Switch India), which is a step-down subsidiary of Optare PLC, UK .

− Earnings vulnerable to fluctuating raw material prices; price hikes and cost-saving measures mitigate impact

The company’s raw material prices are vulnerable to sharp fluctuations and its inability to pass through the same will have an impact on earnings.

− Vulnerability to inherent cyclicality and competition in CV industry; revenues from non-CV business mitigate risk to an extent

Around 90% of ALL’s (consolidated excluding NBFC business) revenues were derived from its standalone operations in FY2026.

Could lead to an upgrade

Strengthening of the company’s business and financial profile, through revenue diversification, sustained rise in market share in the CV business, scale-up in EV business, and material improvement in debt metrics on a sustained basis, could be a trigger for improvement in the long-term rating.

Could lead to a downgrade

Downward pressure on the ratings could arise with sustained deterioration in ALL’s financial profile , affected by a sharp market slowdown or material contraction in market share, higher -than-estimated debt-funded capex and/or investments in group companies or dividend payouts. 2 Consolidated operating margins (excluding NBFC subsidiary) www.icra.in Sensitivity Label : Public Page |3

Agency-reported financials (ICRA, 09 Oct 2026)

MetricFY2025FY2026FY2025FY2026
Operating income (OI)₹38,753 Cr₹44,007 Cr₹48,535 Cr₹56,362 Cr
PAT₹3,303 Cr₹3,566 Cr₹3,351 Cr₹3,669 Cr
OPBDIT/OI12.7%13.0%19.0%19.1%
PAT/OI8.5%8.1%6.9%6.5%
Total outside liabilities/Tangible net worth (times)1.20×1.20×4.10×4.40×
Total debt/OPBDIT (times)0.30×0.20×5.40×6.00×
Interest coverage (times)22.70×33.80×2.30×2.30×
Revenue growth (YoY)—13.6%10.3%16.1%
EBITDA (margin × income)₹4,922 Cr₹5,721 Cr₹9,222 Cr₹10,765 Cr
Implied total debt (debt/EBITDA × EBITDA)₹1,476 Cr₹1,144 Cr₹49,797 Cr₹64,591 Cr
Implied interest cost (EBITDA ÷ coverage)₹217 Cr₹169 Cr₹4,009 Cr₹4,681 Cr

Borrowings & rated debt

Rated borrowing limits (latest)₹7,379 Cr
Peak rated limits₹9,900 CrMar 2020 · CARE
Limits raised1 time1 new facility rated
Weighted average coupon7.42%

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Commercial paperCommercial paper₹2,000 Cr₹2,000 Cr0.0% A1+ReaffirmedICRA
Non-convertible debenture Non-convertibleDebentures & bonds₹200 Cr₹200 Cr0.0% AA+ (Stable)ReaffirmedICRA
debentureDebentures & bonds₹300 Cr₹300 Cr0.0% AA+ (Stable)ReaffirmedICRA
Long term Short term: Fund-based limitsWorking capital & bank lines₹2,000 Cr₹2,000 Cr0.0% AA+ / A1+ (Stable)ReaffirmedICRA
Long term Short term: Non-fund based limitsNon-fund based limits₹1,500 Cr₹1,500 Cr0.0% AA+ / A1+ (Stable)ReaffirmedICRA
Term loansTerm loans₹729 Cr₹629 Cr−13.7% AA+ (Stable)ReaffirmedICRA
Long term Short term: UnallocatedWorking capital & bank lines₹750 Cr₹750 Cr0.0% AA+ / A1+ (Stable)ReaffirmedICRA

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
INE208A07406convertibleDebentures & bonds7.30% —— ₹200 CrAA+ Not stated
INE208A08115convertibleDebentures & bonds7.50% —— ₹300 CrAA+ Not stated
—Term loans FY FYTerm loans— 31 Mar 202031 Mar 2025 ₹629 CrAA+ Matured
INE208A14CO1—Commercial paper6.40% 21 Sep 202219 Dec 2022 ₹500 CrA1+ Matured

CARE ratings on record (checked 24 Oct 2026)

InstrumentAmountRating
BG/LC₹1,500 CrCARE AA+; Stable / CARE A1+
Commercial Paper (Standalone)₹2,000 CrCARE A1+
Long Term—Withdrawn
LT/ST₹200 CrCARE AA+; Stable / CARE A1+
Non Convertible Debentures—Withdrawn
Working Capital Limits₹300 CrCARE A1+
Working Capital Limits₹2,000 CrCARE AA+; Stable / CARE A1+

Lenders

Fund-based - LT/ STWorking Capital LimitsAxis Bank Ltd.
Fund-based - LT/ STWorking Capital LimitsBank of Baroda
Fund-based - LT/ STWorking Capital LimitsCentral Bank of India
Fund-based - LT/ STWorking Capital LimitsCiti Bank
Fund-based - LT/ STWorking Capital LimitsDBS Bank India Ltd.
Fund-based - LT/ STWorking Capital LimitsFederal Bank
Fund-based - LT/ STWorking Capital LimitsHDFC Bank Ltd.
Fund-based - LT/ STWorking Capital LimitsICICI Bank Ltd.
Fund-based - LT/ STWorking Capital LimitsIDBI Bank Ltd.
Fund-based - LT/ STWorking Capital LimitsMUFG Bank Ltd.
Fund-based - LT/ STWorking Capital LimitsStandard Chartered Bank
Fund-based - LT/ STWorking Capital LimitsState Bank of India
Fund-based - LT/ STWorking Capital LimitsYes Bank Ltd.
Fund-based - STWorking Capital LimitsSouth Indian Bank Ltd.
Fund-based/Non-fund-basedLT/STUnallocated
Non-fund-based - LT/ STBG/LCAxis Bank Ltd.
Non-fund-based - LT/ STBG/LCBank of Baroda
Non-fund-based - LT/ STBG/LCCentral Bank of India
Non-fund-based - LT/ STBG/LCCiti Bank
Non-fund-based - LT/ STBG/LCHDFC Bank Ltd.
Non-fund-based - LT/ STBG/LCICICI Bank Ltd.
Non-fund-based - LT/ STBG/LCIDBI Bank Ltd.
Non-fund-based - LT/ STBG/LCMUFG Bank Ltd.
Non-fund-based - LT/ STBG/LCState Bank of India
Non-fund-based - LT/ STBG/LCYes Bank Ltd.

Credit assessment · Commercial vehicles

Rating Methodology – Commercial Vehicles (Sep 2026) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStrongAgency: Strong
DirectionRating watch – DevelopingAgency outlook: Stable
ICRA rating · Oct 2026AA+Matches indicative band

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)68%
Information on file78% · missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 68% (Mostly stable) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹7,379 Cr
Not yet allocated₹750 Cr
Extra debt within 3.5× EBITDA—
Interest coverage2.30×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 68% chance the next rating action is stable or better
  • Current rating AA+ (investment grade)
  • Interest coverage 2.3×
  • ₹750 cr of rated limits not yet tied to a lender

What happened, step by step

Refinanced bank debt with equity
  1. Sep 2026 — ₹300 cr raised through equity
  2. Sep 2026 — Debt-free repayment of debt-free

“ALL has approved an equity infusion of up to ₹300 crore in OHM by March 31, 2027, while the group is also developing a greenfield battery-pack manufacturing facility at Pillaipakkam, involving an investment of ₹400-500 crore.”

Refinanced bank debt with term loans
  1. Mar 2021 — Rated term loans fell from ₹3,700 cr to ₹0 cr
  2. Apr 2021 — ₹1,215 cr raised through term loans
  3. Apr 2021 — Full repayment of debt

“Overall gearing of ALL as on March 31, 2020 stood at 0.52x as against 0.08x as on March 31, 2019 as the company had raised around Rs.1,215 crore of long term debt during the year for capex.”

Rated limits by facility

Timeline

09 Oct 2026 ICRA reaffirmed: AA+ (Stable)Rated limits ₹7,379.38 cr ICRA rationale
09 Oct 2026 Cash & liquid funds ₹7,000 cr, undrawn lines ₹2,000 cr
From the report

ALL’s liquidity position is strong, supported by cash and liquid investments of around Rs. 7,000 crore (standalone) and undrawn bank lines of around Rs. 2,000 crore as on June 30, 2026.

ICRA rationale
09 Oct 2026 Debt repayments due in FY2027: ₹676.7 cr
From the report

Against these sources of cash, it has debt repayment obligations of Rs. 676.7 crore in FY2027 on existing loans.

ICRA rationale
21 Sep 2026 CARE reaffirmed: AA+ (Stable)Rated limits ₹6,000 cr CARE rationale
21 Sep 2026 Cash & liquid funds ₹8,387 cr
From the report

Ratings also derive comfort from ALL's strong liquidity position, with cash and liquid investments of ₹8,387 crore and a net cash position of ₹3,303 crore as on March 31, 2026.

CARE rationale
21 Sep 2026 Debt-free repayment of debt-free
From the report

Rating sensitivities: Factors likely to lead to rating actions Positive factors • Substantially improving operating margins, supported by significantly improving market share across business segments and revenue diversification, while sustaining its auto debt-free status. 1SEBI: Securities and Exchange Board of India;

CARE rationale
21 Sep 2026 Debt-free repayment of debt-free
From the report

The automobile business remained net debt-free and reported a net cash position.

CARE rationale
21 Sep 2026 Cash & liquid funds ₹8,387.49 cr
From the report

Liquidity: Strong ALL’s automobile business maintained a strong liquidity profile, with cash and liquid investments increasing to ₹8,387.49 crore at the end of FY26 (PY: ₹7,246.30 crore).

CARE rationale
21 Sep 2026 ₹300 cr raised through equity
From the report

ALL has approved an equity infusion of up to ₹300 crore in OHM by March 31, 2027, while the group is also developing a greenfield battery-pack manufacturing facility at Pillaipakkam, involving an investment of ₹400-500 crore.

CARE rationale
02 Jun 2026 ICRA reaffirmed: AA+ (Stable)Rated limits ₹7,479.38 cr ICRA rationale
02 Jun 2026 Cash & liquid funds ₹3,800 cr, undrawn lines ₹2,000 cr
From the report

ALL’s liquidity position is strong, supported by cash and liquid investments of over Rs. 3,800.0 crore (standalone) and undrawn bank lines of over Rs. 2,000 crore as on December 31, 2025.

ICRA rationale
22 Sep 2025 CARE reaffirmed: AA+ (Stable)Rated limits ₹6,400 cr CARE rationale
22 Sep 2025 Debt-free repayment of debt-free
From the report

Rating sensitivities: Factors likely to lead to rating actions Positive factors • Substantially improving operating margins, supported by significantly improving market share across business segments and revenue diversification, and sustaining its automotive debt-free status.

CARE rationale
22 Sep 2025 Debt-free repayment of debt-free
From the report

CareEdge Ratings expects the company’s capital structure and debt coverage indicators to remain comfortable and sustai n its net debt-free status for automotive business, as capital expenditure requirements are primarily expected to be met through internal accruals and available liquidity. 2 CARE Ratings Ltd.

CARE rationale
22 Sep 2025 Cash & liquid funds ₹6,533.82 cr
From the report

Press Release Liquidity: Strong ALL’s automotive business has strong liquidity, with cash and liquid investments of ~₹6,533.82 crore as on March 31, 2025, and expected strong cash accruals of ~₹4,000 crore in FY26.

CARE rationale
26 Sep 2024 CARE upgraded: AA+ (Stable)Rated limits ₹6,500 cr CARE rationale
26 Sep 2024 Debt-free repayment of debt-free
From the report

Rating sensitivities: Factors likely to lead to rating actions Positive factors • Substantially improving operating margins, supported by significantly improving market share across business segments and revenue diversification, resulting in a net auto debt-free status on a sustained basis.

CARE rationale
26 Sep 2024 Full repayment of debt
From the report

Improvement in the financial risk profile in FY24 Overall gearing of auto business, as on March 31, 2024, improved to 1.14x (PY: 1.37x) with lower debt levels due to scheduled repayment of debt obligations.

CARE rationale
26 Sep 2024 Cash & liquid funds ₹2,594 cr
From the report

Liquidity: Strong ALL’s auto business has strong liquidity, with cash and liquid investments of ₹2,594 crore as on March 31, 2024, and expected strong cash accruals of over ₹3,000 crore in FY25.

CARE rationale
04 Oct 2023 CARE reaffirmed: AA (Stable)Rated limits ₹6,700 cr CARE rationale
04 Oct 2023 Debt-free repayment of debt-free (₹3,553.88 cr)
From the report

Press Release ₹3,553.88 crore) and became net debt-free as on March 31, 2023.

CARE rationale
04 Oct 2023 Cash & liquid funds ₹3,225.53 cr
From the report

Liquidity: Strong On a standalone basis, ALL has strong liquidity, with cash and liquid investments of ₹3,225.53 crore as on March 31, 2023.

CARE rationale
04 Oct 2023 Cash & liquid funds ₹3,643.51 cr
From the report

On a consolidated basis (excluding HLFL) too, ALL has strong liquidity, with cash and liquid investments of ₹3,643.51 crore as on March 31, 2023.

CARE rationale
07 Nov 2022 CARE reaffirmed: AA (Stable)Rated limits ₹4,100 cr CARE rationale
07 Nov 2022 New borrowing arranged: ₹450 cr (NCDs / bonds)
From the report

The long-term debt was primarily availed in the form of rupee term loan and non-convertible debenture (NCD) of ₹450 crore and ₹200 crore respectively for funding the capex.

CARE rationale
07 Nov 2022 Debt free repayment of debt free
From the report

However, it is expected to come down in FY24 and be net-debt free in FY25.

CARE rationale
07 Nov 2022 Cash & liquid funds ₹2,792.3 cr
From the report

Liquidity: Strong ALL has strong liquidity with cash and liquid investments of ₹2,792.30 crore as on March 31, 2022.

CARE rationale
07 Jan 2022 CARE reaffirmed: AA (Negative)Rated limits ₹4,200 cr CARE rationale
07 Jan 2022 Cash & liquid funds ₹2,012 cr
From the report

Press Release Liquidity: Adequate ALL has adequate liquidity with cash and liquid investments of Rs. 2,012 crore as on September 30, 2021.

CARE rationale
08 Apr 2021 CARE reaffirmed: AA (Negative)Rated limits ₹4,200 cr CARE rationale
08 Apr 2021 ₹1,215 cr raised through term loans
From the report

Overall gearing of ALL as on March 31, 2020 stood at 0.52x as against 0.08x as on March 31, 2019 as the company had raised around Rs.1,215 crore of long term debt during the year for capex.

CARE rationale
08 Apr 2021 Cash & liquid funds ₹1,145 cr
From the report

Liquidity: Adequate ALL has sufficient liquidity with cash and liquid investments of Rs. 1,145 crore as on December 31, 2020.

CARE rationale
08 Apr 2021 Full repayment of debt (₹213 cr)
From the report

ALL has repaid debt obligations of Rs. 213 crore in FY21 and repayment obligation for FY22 is nil.

CARE rationale
26 Mar 2021 CARE reaffirmed: A1+Rated limits ₹2,000 cr CARE rationale
26 Mar 2021 ₹1,072 cr raised through term loans
From the report

During 9mFY20, ALL has raised term debt to the tune of Rs. 1,072 crore to fund its capex resulting in overall gearing of 0.33x as on December 31, 2019.

CARE rationale
26 Mar 2021 Cash & liquid funds ₹1,145 cr
From the report

Liquidity: Adequate ALL has sufficient liquidity with cash and liquid investments of Rs. 1,145 crore as on December 31, 2020.

CARE rationale
26 Mar 2021 Rated term loans fell from ₹3,700 cr to ₹0 cr CARE rationale
06 May 2020 CARE revised: AA (Negative)Rated limits ₹4,200 cr CARE rationale
06 May 2020 ₹1,072 cr raised through term loans
From the report

Overall gearing of ALL as on March 31, 2019 stood at 0.08x as against 0.18x as on March 31, 2018.During 9mFY20, ALL has raised term debt to the tune of Rs.1,072 crore to fund its capex resulting in overall gearing of 0.33x as on December 31, 2019.

CARE rationale
06 May 2020 Cash & liquid funds ₹1,279 cr
From the report

Liquidity: Adequate ALL has sufficient liquidity with cash and bank balance of Rs. 1,279 crore as on March 31, 2020 and relatively low repayment obligation of Rs. 218.30 crore for FY21 as compared to GCA of Rs.800 crore during 9mFY20.

CARE rationale
06 May 2020 Debt repayments due in FY21: ₹218.3 cr
From the report

Liquidity: Adequate ALL has sufficient liquidity with cash and bank balance of Rs. 1,279 crore as on March 31, 2020 and relatively low repayment obligation of Rs. 218.30 crore for FY21 as compared to GCA of Rs.800 crore during 9mFY20.

CARE rationale
06 May 2020 Average working-capital utilisation 40.62%
From the report

Average working capital utilization levels (CC & CP combined) for one year period ended January 2020 increased to 40.62% compared to 14% in previous year for same time period.

CARE rationale
01 Apr 2020 CARE other: — CARE rationale
01 Apr 2020 Debt repayments due in FY20: ₹234 cr
From the report

Liquidity: Adequate ALL has sufficient liquidity with GCA of Rs. 800 Crore during 9mFY20 vis -à-vis scheduled repayment obligations of Rs.234 crore for FY20 and its average CC utilization is around 22.2 6%.

CARE rationale
01 Apr 2020 Cash & liquid funds ₹697 cr
From the report

Cash and bank balance as on December 31, 2019 stood at Rs.697 crore.

CARE rationale
01 Apr 2020 Average working-capital utilisation 40.62%
From the report

However average working capital utilization levels (CC & CP combined) for o ne year period ended January 2020 increased to 40.62% compared to 14 % in previous year for same time period.

CARE rationale
24 Mar 2020 CARE reaffirmed: AA+ (Negative)Rated limits ₹9,900 cr CARE rationale
24 Mar 2020 Debt repayments due in FY20: ₹234 cr
From the report

Liquidity: Adequate ALL has sufficient liquid ity with GCA of Rs. 800 Crore during 9mFY20 vis -à-vis scheduled repayment obligations of Rs.234 crore for FY20 and its average CC utilization is around 22.2 6%.

CARE rationale
24 Mar 2020 Cash & liquid funds ₹697 cr
From the report

Cash and bank balance as on December 31, 2019 stood at Rs.697 crore.

CARE rationale
24 Mar 2020 Average working-capital utilisation 40.62%
From the report

However average working capital utilization levels (CC & CP combined) for one year period ended J anuary 2020 increased to 40.62% compared to 14 % in previous year for same time period.

CARE rationale
28 Jun 2019 CARE reaffirmed: A1+Rated limits ₹2,000 cr CARE rationale
28 Jun 2019 Cash & liquid funds ₹2,740 cr
From the report

During FY19 also ALL generated gross cash accruals of Rs.2,740 crore.

CARE rationale
28 Jun 2019 Average working-capital utilisation 18%
From the report

Average working capital utilization levels for one year period ended May 2019 remained comfortable at 18%.

CARE rationale
05 Apr 2019 CARE reaffirmed: AA+ (Stable)Rated limits ₹2,600 cr CARE rationale
05 Apr 2019 Cash & liquid funds ₹1,780 cr
From the report

During 9mFY19 also ALL generated gross cash accruals of Rs.1,780 crore.

CARE rationale
05 Apr 2019 Average working-capital utilisation 14%
From the report

Average working capital utilization levels for one year period ended January 2019 remained comfortable at 14%.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeNO.1, SARDAR PATEL ROAD GUINDY, CHENNAI, IN-TN, 600032
GSTIN—
Email—
Websitehttps://www.ashokleyland.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Ashok Leyland

Competitors10identified
Locations3most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Tata Motors Passenger Vehicles Gears, Steering, Brakes & Systems · Auto Components, Forging & Casting tata.cars 1945 Mumbai, India
Mahindra and Mahindra Manufacturing · Automobile and Tractor Manufacturing mahindra.com 1945 Mumbai, India
Maruti Suzuki India Passenger Cars · Automobile Manufacturers marutisuzuki.com 1981 New Delhi, India
Tata Motors Outlets operated by Sri Lakshmi Motors. tatamotors.com 1945 Mumbai, India
Hyundai Motor India Part of Hyundai Motor Company. hyundai.com/in/en — Kanchee- -puram, India
Skoda Auto Volkswagen India Part of Volkswagen Group. skoda-vw.co.in 2007 Pune, India
Force Motors Commercial Vehicles & Buses · Automobile Manufacturers forcemotors.com 1958 Pune, India
Varun Motors Passenger Cars · Automobile Manufacturers — — Andhra Pradesh, India
Neon Motors Private Limited Passenger Cars · Automobile Manufacturers — — Andhra Pradesh, India
V.s.t.motors Private Limited Passenger Cars · Automobile Manufacturers — — Chennai, Tamil Nadu, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Group companies

Business activities and related parties

Trucks, buses and light commercial vehicles

Filings

No filings on record yet.